Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
Globin Solutions, Inc. is a pre-clinical stage biopharmaceutical company developing a fast-acting antidote for carbon monoxide poisoning. It plans to advance its lead compound through preclinical testing toward regulatory clearance for clinical trials, working with globin chemistry and protein engineering researchers via sponsored research agreements with the University of Pittsburgh.
0 investors
GO Therapeutics mines the cancer glycoproteome for cancer-specific epitopes and develops high-affinity antibodies used to create ADCs, CAR T cell therapies, and companion diagnostics targeting solid tumors. The company runs in-house and partnered drug discovery programs based on its glycopeptide biology platform.
0 investors
0 investors
Goldenrod Therapeutics develops brain-penetrant phosphodiesterase 4 inhibitors for neurological and neuropsychiatric disorders, focusing on overcoming tolerability limitations of earlier PDE4 inhibitors to address neuroinflammation.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Grace Therapeutics is a biopharmaceutical company developing therapies for aneurysmal subarachnoid hemorrhage (aSAH), a condition with high mortality and morbidity that affects a relatively young patient population. The company is publicly traded and provides investor updates on its drug development pipeline.
0 investors
0 investors
Gravitas Medical develops the Entarik Feeding Tube System, a medical device that assists in feeding tube placement and continuously monitors tube position using bio-impedance sensors and safety alerts. The system is designed for healthcare facilities and ICU nurses managing enteral nutrition for patients unable to feed orally.
0 investors
0 investors
0 investors
Green Dot Bioplastics is a bioscience company that develops and produces biobased, compostable, and recyclable plastics, including its Terratek line of bioplastics. It offers product development and materials expertise to companies making sustainable products.
0 investors
Green Leaf Lab operates cannabis and hemp analytical testing laboratories offering compliance testing for pesticides, potency, solvents, terpenes, and heavy metals, as well as product development services. It serves licensed cannabis industry clients in Oregon and California and is ISO 17025 accredited.
0 investors
0 investors
Greenwich LifeSciences is a clinical-stage biopharmaceutical company developing GP2, a peptide immunotherapy targeting the HER2/neu protein, aimed at preventing breast cancer recurrence. It is running Flamingo-01, a global Phase III trial evaluating its GLSI-100 candidate in HER2/neu positive breast cancer patients.
0 investors
Greyledge Technologies develops diagnostic and cell-analysis equipment and services for regenerative medicine practitioners to characterize biologic treatments like PRP and stem cell therapies. The company works with physicians and biotech providers to enable precise cell quantification and FDA-compliant cellular therapy delivery.
0 investors
Grib Bio is developing a pipeline of NKT cell modulators aimed at treating inflammatory, fibrotic, and autoimmune diseases by targeting early steps in the inflammatory cascade. It operates in the biotechnology and drug development sector.
0 investors